Phibro Animal Health Corporation revenue by segment PAHC

Annual Quarterly

Phibro Animal Health Corporation splits its revenue into 5 lines in its filings. The largest line in fiscal 2026, which ended Jun 30, 2026 was Medicated Feed Additives And Others at $810.7 million, 53% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2027 Sep 30, 2026	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021	FY 2020 Jun 30, 2020	FY 2019 Jun 30, 2019	FY 2018 Jun 30, 2018	FY 2017 Jun 30, 2017
Revenue	1,541	1,518	1,296	1,018	978	942	833	800	828	820	764
Medicated Feed Additives And Others	822 +12.0% share 53.3%	811 +25.4% share 53.4%	646 +53.5% share 49.9%	421 +8.7% share 41.4%	387 +7.1% share 39.6%	362 +9.6% share 38.4%	330 +2.4% share 39.6%	322 share 40.3%	—	—	—
Mineral Nutrition	293 +13.9% share 19.0%	282 +11.5% share 18.6%	253 +3.9% share 19.5%	244 +0.4% share 23.9%	243 -6.5% share 24.8%	260 share 27.5%	—	—	—	—	—
Nutritional Specialties	194 +5.0% share 12.6%	195 +8.8% share 12.8%	179 +8.9% share 13.8%	165 -4.5% share 16.2%	173 +9.7% share 17.6%	157 +10.1% share 16.7%	143 +10.4% share 17.1%	129 share 16.2%	—	—	—
Vaccines	156 +7.3% share 10.1%	156 +14.0% share 10.3%	137 +13.5% share 10.6%	121 +20.9% share 11.9%	100 +13.2% share 10.2%	88 +21.1% share 9.4%	73 -3.2% share 8.8%	75 share 9.4%	—	—	—
Performance Products	76 -3.2% share 4.9%	74 -8.3% share 4.8%	80 +18.7% share 6.2%	68 -10.4% share 6.6%	75 -0.4% share 7.7%	76 share 8.0%	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: PAHC (Nasdaq)
Fiscal year ends: June 30
Incorporated in: DE
Headquarters: Teaneck, NJ
SEC filer status: Large accelerated filer
SEC CIK: 1069899
Former names: PHILIPP BROTHERS CHEMICALS INC (until May 14, 2003)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.